DrugDashboards

Market view

dactylis glomerata

10 marketed package NDCs · 2 active manufacturers

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

Same drug class

Other molecules FDA puts in Standardized Pollen Allergenic Extract, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Dactylis glomerata in shortage right now?
No. FDA does not currently list Dactylis glomerata in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Dactylis glomerata?
2 companies have marketed Dactylis glomerata in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.